MedTech Dive September 26, 2018
Susan Kelly

Dive Brief:

  • The medtech industry is projected to grow at a compound annual rate of 5.6% worldwide from 2017 through 2024, reaching $595 billion, according to a new analysis from Evaluate Ltd. that also ranks fastest-growing specialties, biggest companies and top R&D spenders.
  • Total medtech R&D spending is seen growing by 4.5% to hit $39 billion by 2024. Medtronic, the biggest medical device maker by sales, is also the biggest R&D spender, but smaller players such as Edwards Lifesciences and bioMérieux invest a much larger percentage of their sales in R&D.
  • The number of new devices receiving first-time FDA approval in 2017 matched a previous 10-year high set in 2015.

Dive Insight:

With FDA working on a...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: FDA, Govt Agencies, Market Research, Medical Devices, Trends
Spinoffs, sales and tuck-ins top medtech deal priorities: Moody’s
Bayer and ASPIVIX collaborate on women’s health device
STAT+: Medicare official says breakthrough device reimbursement rule coming in early summer
Brain-computer interface research reaches new frontiers
Opinion: STAT+: How AI can help satisfy FDA’s drug, device diversity requirements

Share This Article